DLC-1通过Rho通路抑制耐恩杂鲁胺前列腺癌细胞的增殖与侵袭能力

汤洋斌 , 杨果 , 吴小候 , 全真

重庆医科大学学报 ›› 2024, Vol. 49 ›› Issue (10) : 1061 -1066.

PDF (3446KB)
重庆医科大学学报 ›› 2024, Vol. 49 ›› Issue (10) : 1061 -1066. DOI: 10.13406/j.cnki.cyxb.003595
基础研究

DLC-1通过Rho通路抑制耐恩杂鲁胺前列腺癌细胞的增殖与侵袭能力

作者信息 +

Deleted in liver cancer-1 inhibits the proliferation and invasion of enzalutamide-resistant prostate cancer cells via the Rho pathway

Author information +
文章历史 +
PDF (3527K)

摘要

目的 探索肝癌缺失因子1(deleted in liver cancer 1,DLC-1)对耐恩杂鲁胺前列腺癌(prostate cancer,PCa)细胞增殖,侵袭和凋亡的影响以及作用机制。 方法 体外以不同浓度的恩杂鲁胺药物培养人前列腺癌lncap及C4-2细胞株6个月以上,构建恩杂鲁胺耐药细胞系lncap-R,C4-2-R。CCK-8法检测其IC50,验证恩杂鲁胺耐药株是否构建成功。利用慢病毒转染lncap-R,C4-2-R,以敲低和过表达DLC-1,采用克隆实验、Transwell实验和流式细胞术检测DLC-1对耐恩杂鲁胺的前列腺癌细胞的增殖、侵袭和凋亡的影响。 结果 与对照组相比,过表达组DLC-1显著抑制了2个耐药株的增殖和侵袭进程。机制上,WB实验结果表明DLC-1表达与2个耐药株中Rho蛋白的表达呈负相关。Rho抑制剂rhosin逆转了因敲低DLC-1后lncap-R细胞凋亡减少的情况。 结论 DLC-1可以下调耐药株中的Rho蛋白的表达,并抑制耐药株的增殖和侵袭。

Abstract

Objective To investigate the effect of deleted in liver cancer-1(DLC-1) on the proliferation,invasion,and apoptosis of enzalutamide-resistant prostate cancer cells and its mechanism of action. Methods Hμmol/Lan prostate cancer lncap and C4-2 cell lines were cultured in vitro with different concentrations of enzalutamide for more than 6 months,and enzalutamide-resistant cell lines were constructed as lncap-R and C4-2-R. IC50 was measured by CCK-8 assay to verify the successful construction of enzalutamide-resistant cell lines. lncap-R and C4-2-R were transfected by lentivirus to achieve the knockdown and overexpression of DLC-1,and colony formation assay,Transwell assay,and flow cytometry were used to observe the effect of DLC-1 on the proliferation,invasion,and apoptosis of enzalutamide-resistant prostate cancer cells. Results Compared with the control group,the overexpression group showed that DLC-1 significantly inhibited the proliferation and invasion of the two enzalutamide-resistant cell lines. As for mechanism of action,Western blot showed that the expression of DLC-1 was negatively correlated with the expression of Rho protein in both enzalutamide-resistant cell lines. The Rho inhibitor rhosin reversed the reduction in the apoptosis of lncap-R cells due to knockdown of DLC-1. Conclusion DLC-1 can downregulate the expression of Rho protein in drug-resistant cell lines and inhibit their proliferation and invasion.

关键词

肝癌缺失因子1 / 前列腺癌 / 恩杂鲁胺 / Rho蛋白 / 增殖 / 侵袭

Key words

deleted in liver cancer-1 / prostate cancer / enzalutamide / Rho protein / proliferation / invasion

引用本文

引用格式 ▾
汤洋斌, 杨果, 吴小候, 全真 DLC-1通过Rho通路抑制耐恩杂鲁胺前列腺癌细胞的增殖与侵袭能力[J]. 重庆医科大学学报, 2024, 49(10): 1061-1066 DOI:10.13406/j.cnki.cyxb.003595

登录浏览全文

4963

注册一个新账户 忘记密码

参考文献

基金资助

国家自然科学基金资助项目(81802543)

AI Summary AI Mindmap
PDF (3446KB)

17

访问

0

被引

详细

导航
相关文章

AI思维导图

/